Journal Publications

Full citation data: Pubmed, Web of Science, Google Scholar

† equal contribution | ‡ co-corresponding author

    1. Holt BA†, Lim HS†, Su M, Tuttle M, Liakakos H, Qiu P‡, and Kwong GA‡, “Embracing enzyme promiscuity with activity-based compressed biosensing” bioRxiv 2022.01.04.474983 preprint.
    2. Gamboa L, Zamat AH, Vanover D, Thiveaud CA, Peck HE, Phuengkham H, Sivakumar A, Harris AM, Dahotre SN, Su FY, Santangelo PJ, and Kwong GA, “Sensitizing solid tumors to CAR-mediated cytotoxicity using synthetic antigens” bioRxiv 2021.12.11.472238 preprint
    3. Su FY, Zhao QY, Dahotre SD, Gamboa L, Bawage SS, Silva Trenkle AD, Zamat A, Phuengkham H, Ahmed R, Santangelo P, and Kwong GA, “In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles” in press, Sci. Adv. preprint.
    4. Mac QD†, Sivakumar A†, Phuengkham H, Xu C, Bowen JR, Su FY, Stentz SZ, Sim H, Harris AM, Li TT, Qiu P, and Kwong GA, “Urinary detection of early responses to checkpoint blockade and discrimination of refractory tumours via antibody-conjugated protease sensors” in press, Nat. Biomed. Eng., bioRxiv 2020.12.10.420265 preprint
    5. Holt BA, Tuttle M, Xu Y, Su M, Roise JJ, Wang X, Murthy N and Kwong GA, “Dimensionless parameter predicts bacterial prodrug success” Mol. Syst. Biol. 18: e10496 (2022). [DOI: 10.15252/msb.202110495]
    1. Cazanave SC, Warren AD, Pacula M, Touti F, Zagorska A, Gural N, Huang EK, Sherman S, Cheema M, Ibarra S, Serer A, Bates J, Billin AN, Liles JT, Budas GR, Breckenridge DG, Tiniakos D, Ratziu V, Daly AK, Govaere O, Anstee QM, Gelrud L, Luther J, Chung RT, Corey KE, Winckler W, Bhatia SN, and Kwong GA, “Peptide-based urinary monitoring of fibrotic non-alcoholic steatohepatitis by mass barcoded activity-based sensors” Sci. Transl. Med. 13, eabe8939 (2021). [DOI: 10.1126/scitranslmed.abe8939]

    Summary | Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease that has been dubbed the silent epidemic as it has few symptoms. When left undiagnosed and untreated, the liver can develop cirrhosis or liver cancer. We developed synthetic biomarkers to diagnosis NASH early, monitor changes in disease severity, and indicate response to treatment.

    1. Miller IC†, Zamat A†, Sun LK, Phuengkham H, Harris AM, Gamboa L, Yang J, Murad JP, Priceman SJ and Kwong GA, “Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control” Nat. Biomed. Eng. 5, 1348–1359 (2021). [DOI: 10.1038/s41551-021-00781-2]

    Summary | Treating solid tumors with chimeric antigen receptor (CAR) T cells typically results in poor responses.  In this study, we developed a new class of CAR T cells that are switched on by localized heating to release potent biologics that are otherwise too toxic to use systemically. Thermal targeting of CAR T cells opens the door for spatial control to potentiate cancer therapy. 

    Press Coverage | Georgia Tech Research Horizons “Heat-controllable CAR T-cells destroy tumors and prevent relapse in new study” | TheScientist “Heating up CAR T cells for cancer therapy” | GEN “CAR T gets hot under the collar for cancer targets” | Mirage News | Newswise | MedicalXpress | The Medical News | Technology Networks | AZO Life Sciences | Front Line Genomics | Science Daily
    1. Kwong GA‡, Ghosh S, Gamboa L, Patriotis C, Srivastava S‡, and Bhatia SN‡, “Synthetic Biomarkers: A 21st century path to early cancer detection” Nat. Rev. Cancer 21, 655–668 (2021). [DOI: 10.1038/s41568-021-00389-3]

    Summary | In 2019, the NCI Division of Cancer Prevention co-organized a think tank meeting on synthetic biomarkers for early detection. We wrote this review to summarize the current science and as a clarion call for more scientists and engineers to work together to solve this important problem. We also dedicated the article to the late Dr. Sam Gambhir, a visionary pioneer and thought leader in bioengineering who devoted his career to developing methods for early disease detection. 

    1. Bazrafshan A, Kyriazi ME, Holt BA, Deng W, Piranej S, Su H, Hu Y, El-Sagheer A, Brown T, Kwong GA, Kanaras A, and Salaita K, “DNA gold nanoparticle motors demonstrate processive motion with bursts of speed up to 50 nm per second” ACS Nano 15(5), 8427–8438 (2021). [DOI: 10.1021/acsnano.0c10658]
    2. Su FY†, Mac QD†, Sivakumar A, and Kwong GA, “Interfacing biomaterials with synthetic T cell immunity” Adv. Healthcare Mater. 10, 2100157 (2021). [DOI: 10.1002/adhm.202100157
    3. Dahotre SN†, Romanov A†, Su FY, and Kwong GA, “Synthetic antigen-presenting cells for adoptive T cell therapy” Adv. Therap. 4, 2100034 (2021). [DOI: 10.1002/adtp.202100034]
    1. Turner TC†, Sok MCP†, Hymel LA†, Pittman F, York WY, Mac QD, Vishna S, Lim HS, Kwong GA, Qiu P, and Botchwey EA, “Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy” Sci. Adv. 6(44), eaba7702 (2020). [DOI: 10.1126/sciadv.aba7702]
    2. Holt BA and Kwong GA, “Protease circuits for processing biological information” Nat. Commun. 11, 5021 (2020). [DOI: 10.1038/s41467-020-18840-8]

    Summary | Biological circuits engineered to interface with living systems will enable new applications for programmable immune therapies and diagnostics. In this study, we explored how treating proteases as ‘biological bits’ could be used to design cell-free biocircuits with the capacity to perform digital operations such as analog-to-digital conversion for drug delivery, as well as analog operations that implement ‘fuzzy logic’ to solve mathematical problems. 

    Press Coverage | Georgia Tech Research Horizons “‘Programmable Medicine’ is the goal for new bio-circuitry research” | Phys.org | Mirage News | TMR Blog
    1. Gamboa L, Zamat A and Kwong GA, “Synthetic immunity by remote control” Theranostics 10(8): 3652–3667 (2020). [DOI: 10.7150/thno.41305]
    2. Kwong GA, “Macrophage sensors for early cancer detection” Clin. Chem. 66(2), 268–270 (2020). [DOI: 10.1093/clinchem/hvz017]
    3. Tadros AR, Romanyuk A, Miller IC, Santiago A, Noel RK, O’Farrell L, Kwong GA and Prausnitz MR, “STAR particles for enhanced topical drug and vaccine delivery” Nat. Med. 26, 341–347 (2020). [DOI:10.1038/s41591-020-0787-6]
    4. Gamboa L, Phung EV, Li H, Meyers JP, Miller IC and Kwong GA, “Heat-triggered remote control of CRISPR-dCas9 for tunable transcriptional modulation” ACS Chem. Biol. 15(2), 533–542 (2020). [DOI: 10.1021/acschembio.9b01005]
    Summary | CRISPR-based approaches have achieved wide success in modulating gene activity to control cell function and are potential tools for clinical therapies. However, the lack of precise methods to deliver and control Cas protein expression in vivo remains a critical hurdle. Here we develop a tunable, heat-triggered platform that regulates mammalian cell transcription by remote control of dCas9 transcriptional modulators.